severe cases – Page 29 – Communicable Diseases Research

Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study

중국 뇌졸중 코로나19 환자의 임상적 특징과 치료 결과: 다기관 후향적 연구

Multicenter Study

Published on 2021-01-012022-09-11
Journal: Phytomedicine : international journal of phytother [Category] 치료법, 치료제,

Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome – temporarily associated with SARS-CoV-2 admitted under adult medicine

이달의 교훈: 소아 염증성 다기관 증후군이 있는 오해받은 십대 - 성인 의학으로 입원한 SARS-CoV-2와 일시적으로 연관됨

Case Reports

Published on 2021-01-012022-09-12
Journal: Clinical medicine (London, England) [Category] MERS, 진단,

Pulmonary function and health-related quality of life after COVID-19 pneumonia

Observational Study

Published on 2021-01-012022-10-04
Journal: Respiratory medicine [Category] 임상,

Prediction on the number of confirmed Covid-19 with the FUDAN-CCDC mathematical model and its epidemiology, clinical manifestations, and prevention and treatment effects

Research article

Published on 2021-01-012022-10-05
Journal: Results in Physics [Category] 치료법,

[키워드] accompanied age analyzed average center Characteristics Chinese clinical manifestation clinical manifestations Clinical symptoms confirmed case Control cough COVID-19 COVID-19 patient COVID-19 patients Critical case cumulative drug Efficacy epidemiological epidemiological history Epidemiology Fever FUDAN-CCDC mathematical model initial symptom injection Laboratory Laboratory test Laboratory tests less Local lymphocyte mathematical mild cases moderate MOST Novel coronavirus novel coronavirus pneumonia nucleic acid Older Patient patients with COVID-19 PCT Pneumonia predict predicted prediction Prevention and treatment effects procalcitonin Research Respiratory failure severe cases sodium statistical Symptoms Tablet the patient Treatment treatment effect WHO with COVID-19 World Health Organization Wuhan
[DOI] 10.1016/j.rinp.2020.103618 [Article Type] Research article

Risk factors related to the severity of COVID-19 in Wuhan

Research Paper

Published on 2021-01-012022-10-29
Journal: International Journal of Medical Sciences [Category] COVID-19, MERS,

[키워드] Accuracy Admission can be used cardiac troponin center characteristic Characteristics Chest Classifier clinical Clinical characteristics Cohort collected Combination compared and analyzed contribute contributed COVID-19 defined discharged disease severity distress early stage evaluate Factor feature FIVE High-sensitivity C-reactive protein identify interleukin-6 Laboratory laboratory-confirmed linear Logistic regression Logistic regression analysis machine learning Machine learning algorithms mild case mild cases moderate moderate cases Moderate COVID-19 outcomes Patient patients patients with moderate procalcitonin Prognosis prognostic prognostic prediction Retrospective study risk factor Risk factors sensitivity severe cases severe disease severe prognosis severity severity of COVID-19 significant difference significantly specificity statistical test Support the disease two group two groups Union Hospital was performed Wuhan
[DOI] 10.7150/ijms.47193 PMC 바로가기 [Article Type] Research Paper

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

중증 COVID-19 사례 관리에 대한 정맥 면역글로불린(IVIg)의 효과 평가: 무작위 대조 시험

Randomized Controlled Trial

Published on 2021-01-012022-09-11
Journal: International immunopharmacology [Category] SARS, 임상, 진단, 치료제,

[키워드] Admission both groups Combination control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demographic data dose Effect Evaluating Factors group hospital Hospital admission Hospital stay Hydroxychloroquine ICU Immunoglobulin Infection intensive care unit intervention group Intravenous immunoglobulin IVIG Lopinavir Lopinavir/ritonavir management mechanical ventilation Mortality mortality rate no significant difference P-value pandemic Patient positive positive relationship Previous studies previous study pulmonary Pulmonary infection Pulmonary infection. Randomized controlled trial reducing Ritonavir severe cases severe COVID-19 significantly lower Support supportive care survivor Treatment two group two groups Viral Viral load were recorded
[DOI] 10.1016/j.intimp.2020.107205 PMC 바로가기 [Article Type] Randomized Controlled Trial

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes

Observational Study

Published on 2021-01-012022-10-05
Journal: Diabetes & metabolic syndrome [Category] 임상,

SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets

SARS-CoV-2 감염은 순환 단핵구에서 혼합 M1/M2 표현형을 유도하고 수지상 세포 및 단핵구 하위 집합 모두에서 변경을 유도합니다

Clinical Trial

Published on 2020-12-312022-08-13
Journal: PLoS ONE [Category] MERS, SARS, 바이오마커, 임상, 진단,

[키워드] activated Activation adoptive immunity alteration Analysis B lymphocytes Cell center circulating monocyte clinical Clinical Center clinical manifestation clinical manifestations COVID-19 patient cytometric dendritic cell dendritic cells event expressed Flow Flow cytometric analysis functional highlight Immunity immunological indicated induce Innate immunity less low expression lymphocyte Lymphocytes M1 and M2 monocytes M2 marker M2 monocyte M2 monocytes marker Mild mild case mild cases Mild symptom mild symptoms monocyte Monocytes myeloid NK cell NK cells Patient Peripheral blood peripheral blood cell peripheral blood cells phenotype phenotypic preserved proportion recruited SARS-COV-2 infection severe cases severe disease severe symptom severity subset Symptom T and B lymphocytes the disease was performed
[DOI] 10.1371/journal.pone.0241097 PMC 바로가기 [Article Type] Clinical Trial

Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update

Review

Published on 2020-12-282022-10-29
Journal: Microorganisms [Category] COVID-19,

[키워드] “cytokine storm” ACE2 acute respiratory syndrome addition affected angiotensin-converting enzyme 2 association clinical manifestation consequence coronavirus COVID-19 COVID-19 patient disease Dysbiosis Evidence Gut gut microbiota gut microbiota dysbiosis hospital human cell immune immune response immune system Increased infect Inflammation inflammatory condition intensive care intestinal knowledge microbiota modulated Older outcome Patient patients phenotype Poor presenting Prevalence pulmonary diseases renal SARS-CoV-2 severe cases Stage suggested susceptibility susceptibility to progress the disease the patient virus receptor
[DOI] 10.3390/microorganisms9010053 PMC 바로가기 [Article Type] Review

SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness

Molecular Biosciences

Published on 2020-12-222022-10-31
Journal: Frontiers in Molecular Biosciences [Category] COVID-19,

[키워드] abdomen ACE2 receptor Acute cardiac injury Acute kidney injury acute respiratory distress axis Characteristics chest pain China clinical manifestation coronavirus country CoV COVID-19 COVID-19 infection COVID-19 virus Cytokine storm death diarrhea disorder Dysbiosis emesis evaluate Exanthema extra-pulmonary organ fatigue Fever gastrointestinal tract Gut-brain axis hemoptysis illness infected with COVID-19 Infection Interaction involved laboratory-confirmed loss of appetite mechanism MERS microbiota Middle East myalgia nausea nervous system neurological occur outbreak Pain pandemic Patient Pneumonia potential mechanism Prophylactic relationship reported respiratory respiratory tract responsible rhinorrhea SARS CoV-2 SARS-CoV-2 severe cases Shock shown sore throat spread to stroke Symptom syndrome Treatment strategies virus WHO
[DOI] 10.3389/fmolb.2020.606779 PMC 바로가기 [Article Type] Molecular Biosciences